Dutton J, Zardab M, De Braal V J F, Hariharan D, MacDonald N, Hallworth S, Hutchins R, Bhattacharya S, Abraham A, Kocher H M, Yip V S
Barts and London HPB Centre, UK.
Department of Anaesthesia, The Royal London Hospital, Barts Health NHS Trust Whitechapel, E1 1BB, UK.
Ann Med Surg (Lond). 2020 Dec 28;62:1-9. doi: 10.1016/j.amsu.2020.12.016. eCollection 2021 Feb.
Cardiopulmonary exercise-testing (CPET) and the (Portsmouth) Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity ((P)-POSSUM) are used as pre-operative risk stratification and audit tools in general surgery, however, both have been demonstrated to have limitations in major hepatopancreatobiliary (HPB) surgery.
The aim of this review is to determine if CPET and (P)-POSSUM scoring systems accurately predict morbidity and mortality. Eligible articles were identified with an electronic database search. Analysis according to surgery type and tool used was performed.
Twenty-five studies were included in the final review. POSSUM predicted morbidity demonstrated weighted O/E ratios of 0.75(95%CI0.57-0.97) in hepatic surgery and 0.85(95%CI0.8-0.9) in pancreatic surgery. P-POSSUM predicted mortality in pancreatic surgery demonstrated an O/E ratio of 0.75(95%CI0.27-2.13) and 0.94(95%CI0.57-1.55) in hepatic surgery. In both pancreatic and hepatic surgery an anaerobic threshold(AT) of between 9 0.5-11.5 ml/kg/min was predictive of post-operative complications, and in pancreatic surgery ventilatory equivalence of carbon dioxide(˙VE/˙VCO2) was predictive of 30-day mortality.
POSSUM demonstrates an overall lack of predictive fit for morbidity, whilst CPET variables provide some predictive power for post-operative outcomes. Development of a new HPB specific risk prediction tool would be beneficial; the combination of parameters from POSSUM and CPET, alongside HPB specific markers could overcome current limitations.
心肺运动试验(CPET)和(朴茨茅斯)生理与手术严重程度评分系统(用于死亡率和发病率的枚举(P)-POSSUM)在普通外科手术中用作术前风险分层和审计工具,然而,两者在主要的肝胰胆(HPB)手术中均已被证明存在局限性。
本综述的目的是确定CPET和(P)-POSSUM评分系统是否能准确预测发病率和死亡率。通过电子数据库搜索确定符合条件的文章。根据手术类型和使用的工具进行分析。
最终综述纳入了25项研究。POSSUM预测的发病率在肝脏手术中的加权观察值与预期值(O/E)比为0.75(95%可信区间0.57 - 0.97),在胰腺手术中为0.85(95%可信区间0.8 - 0.9)。P-POSSUM预测的胰腺手术死亡率的O/E比为0.75(95%可信区间0.27 - 2.13),在肝脏手术中为0.94(95%可信区间0.57 - 1.55)。在胰腺和肝脏手术中,无氧阈值(AT)在9.5 - 11.5毫升/千克/分钟之间可预测术后并发症,在胰腺手术中,二氧化碳通气当量(˙VE/˙VCO2)可预测30天死亡率。
POSSUM总体上对发病率缺乏预测契合度,而CPET变量对术后结果具有一定的预测能力。开发一种新的HPB特异性风险预测工具将是有益的;将POSSUM和CPET的参数与HPB特异性标志物相结合可以克服当前的局限性。